The introduction of the Medicare Part D prescription drug benefits dramatically increased coverage for prescription drugs among Medicare beneficiaries. Part D’s design, however, requires beneficiaries to choose among private plans, creating new challenges for consumers. Beneficiaries often report that choosing a plan is difficult, and research has raised concerns over decision quality in plan choice. Little evidence exists, however, on how to facilitate decision-making and improve decision quality in this context.
